Pharmacologic interventions for the prevention and treatment of retinopathy of prematurity

Blencowe, 2013, Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010, Pediatr Res, 74, 35, 10.1038/pr.2013.205 Rothschild, 2016, Economic Model of Retinopathy of Prematurity (EcROP) Screening and Treatment: Mexico and the United States, Am J Ophthalmol, 168, 110, 10.1016/j.ajo.2016.04.014 Hellström, 2013, Retinopathy of prematurity, Lancet, 382, 1445, 10.1016/S0140-6736(13)60178-6 Hartnett, 2010, The effects of oxygen stresses on the development of features of severe retinopathy of prematurity: knowledge from the 50/10 OIR model, Doc Ophthalmol, 120, 25, 10.1007/s10633-009-9181-x Coleman, 2008, Effects of brief, clustered versus dispersed hypoxic episodes on systemic and ocular growth factors in a rat model of oxygen-induced retinopathy, Pediatr Res, 64, 1, 10.1203/PDR.0b013e31817307ac Aranda, 2016, Pharmacologic synergism of ocular ketorolac and systemic caffeine citrate in rat oxygen-induced retinopathy, Pediatr Res, 80, 554, 10.1038/pr.2016.105 Jivabhai Patel, 2015, Exogenous superoxide dismutase mimetic without scavenging H2O2 causes photoreceptor damage in a rat model for oxygen-induced retinopathy, Invest Ophthalmol Vis Sci, 56, 1665, 10.1167/iovs.14-15321 Beharry, 2013, Hydrogen peroxide accumulation in the choroid during intermittent hypoxia increases risk of severe oxygen-induced retinopathy in neonatal rats, IOVS, 54, 7644 Beharry, 2017, Co-enzyme Q10 and n-3 polyunsaturated fatty acid supplementation reverse intermittent hypoxia-induced growth restriction and improved antioxidant profiles in neonatal rats, Antioxidants (Basel), 6, E103, 10.3390/antiox6040103 Beharry, 2018, Impact of chronic neonatal intermittent hypoxia on severity of retinal damage in a rat model of oxygen-induced retinopathy, J Nat Sci, 4, e488 Beharry, 2018, Oxygen-induced retinopathy from recurrent intermittent hypoxia is not dependent on resolution with room air or oxygen, in neonatal rats, Int J Mol Sci, 19, E1337, 10.3390/ijms19051337 Gao, 2013, Hypoxia/oxidative stress alters the pharmacokinetics of CPU86017-RS through mitochondrial dysfunction and NADPH oxidase activation, Acta Pharmacol Sin, 34, 1575, 10.1038/aps.2013.94 Martin, 2012, Physiologic basis for intermittent hypoxic episodes in preterm infants, Adv Exp Med Biol, 758, 351, 10.1007/978-94-007-4584-1_47 York, 2004, Arterial oxygen fluctuation and retinopathy of prematurity in very-low-birth-weight infants, J Perinatol, 24, 82, 10.1038/sj.jp.7211040 Di Fiore, 2010, A higher incidence of intermittent hypoxemic episodes is associated with severe retinopathy of prematurity, J Pediatr, 157, 69, 10.1016/j.jpeds.2010.01.046 Di Fiore, 2012, The relationship between patterns of intermittent hypoxia and retinopathy of prematurity in preterm infants, Pediatr Res, 72, 606, 10.1038/pr.2012.132 Thylefors, 1998, A global initiative for the elimination of avoidable blindness, Am J Ophthalmol, 125, 90, 10.1016/S0002-9394(99)80239-6 Gilbert, 2001, Childhood blindness in the context of Vision 2020—the right to sight, Bull World Health Organ, 79, 227 Provis, 2001, Development of the primate retinal vasculature, Prog Ret Eye Res, 20, 799, 10.1016/S1350-9462(01)00012-X Chan-Ling, 2018, Pathophysiology, screening and treatment of ROP: a multi-disciplinary perspective, Prog Retin Eye Res, 62, 77, 10.1016/j.preteyeres.2017.09.002 Archer, 1993, A redox-based O2 sensor in rat pulmonary vasculature, Circ Res, 73, 1100, 10.1161/01.RES.73.6.1100 Lisanti, 2011, Hydrogen peroxide fuels aging, inflammation, cancer metabolism and metastasis: the seed and soil also needs “fertilizer”, Cell Cycle, 10, 2440, 10.4161/cc.10.15.16870 Davis, 2010, Maturation of the antioxidant system and the effects on preterm birth, Semin Fetal Neonatal Med, 15, 191, 10.1016/j.siny.2010.04.001 Winterbourn, 1995, The toxicity of iron and hydrogen peroxide: the Fenton reaction, Toxicol Lett, 82-83, 969, 10.1016/0378-4274(95)03532-X Hirano, 2001, Blood transfusion increases radical promoting non-transferrin bound iron in preterm infants, Arch Dis Child Fetal Neonatal Ed, 84, F188, 10.1136/fn.84.3.F188 Halliwell, 1992, Biologically relevant metal ion-dependent hydroxyl radical generation. An update, FEBS Lett, 307, 108, 10.1016/0014-5793(92)80911-Y Rivera, 2011, Understanding retinopathy of prematurity: update on pathogenesis, Neonatology, 100, 343, 10.1159/000330174 LeGoff, 2008, Adult vitreous structure and postnatal changes, Eye, 22, 1214, 10.1038/eye.2008.21 Smith, 2018, Retinopathy of prematurity workgroup of the international neonatal consortium. development of a retinopathy of prematurity activity scale and clinical outcome measures for use in clinical trials, JAMA Ophthalmol, 137, 305, 10.1001/jamaophthalmol.2018.5984 Raghuveer, 2011, A paradigm shift in the prevention of retinopathy of prematurity, Neonatology, 100, 116, 10.1159/000322848 Martin, 2011, Intermittent hypoxic episodes in preterm infants: do they matter?, Neonatology, 100, 303, 10.1159/000329922 Zepeda-Romero, 2013, Early retinopathy of prematurity findings identified with fluorescein angiography, Graefes Arch Clin Exp Ophthalmol, 251, 2093, 10.1007/s00417-013-2321-8 Chen, 2008, Erythropoietin deficiency decreases vascular stability in mice, J Clin Invest, 118, 526 Brown, 2006, Association between higher cumulative doses of recombinant erythropoietin and risk for retinopathy of prematurity, J AAPOS, 10, 143, 10.1016/j.jaapos.2005.09.005 Suk, 2008, Human recombinant erythropoietin and the incidence of retinopathy of prematurity: a multiple regression model, J AAPOS, 12, 233, 10.1016/j.jaapos.2007.08.009 Schneider, 2008, Use of recombinant human erythropoietin and risk of severe retinopathy in extremely low-birth-weight infants, Pharmacotherapy, 28, 1335, 10.1592/phco.28.11.1335 Fang, 2016, Interventions to prevent retinopathy of prematurity: a meta-analysis, Pediatrics, 137, 10.1542/peds.2015-3387 Sullivan, 1988, Iron, plasma antioxidants, and the 'oxygen radical disease of prematurity', Am J Dis Child, 142, 1341 Hesse, 1997, Blood transfusion. Iron load and retinopathy of prematurity, Eur J Pediatr, 156, 465, 10.1007/s004310050641 Schmidt, 2006, Caffeine for apnea of prematurity trial group. Caffeine therapy for apnea of prematurity, NEJM, 354, 2112, 10.1056/NEJMoa054065 Schmidt, 2007, Caffeine for apnea of prematurity trial group. Long-term effects of caffeine therapy for apnea of prematurity, NEJM, 357, 1893, 10.1056/NEJMoa073679 Merighi, 2007, Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells, Mol Pharmacol, 72, 395, 10.1124/mol.106.032920 Liu, 2010, Caffeine induces matrix metalloproteinase-2 (MMP-2) and MMP-9 down-regulation in human leukemia U937 cells via Ca2+/ROS-mediated suppression of ERK/c-fos pathway and activation of p38 MAPK/c-jun pathway, J Cell Physiol, 224, 775, 10.1002/jcp.22180 Tu, 2015, Proteomic profiling of the retinas in a neonatal rat model of oxygen-induced retinopathy with a reproducible ion-current-based MS1 approach, J Proteome Res, 14, 2109, 10.1021/pr501238m Fiebich, 2000, Effects of caffeine and paracetamol alone or in combination with acetylsalicylic acid on prostaglandin E(2) synthesis in rat microglial cells, Neuropharmacology, 39, 2205, 10.1016/S0028-3908(00)00045-9 Dooley, 2007, Caffeine as an adjuvant to ibuprofen in treating childhood headaches, Pediatr Neurol, 37, 42, 10.1016/j.pediatrneurol.2007.02.016 Hellström, 2003, Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth, Pediatrics, 112, 1016, 10.1542/peds.112.5.1016 Smith, 2005, IGF-1 and retinopathy of prematurity in the preterm infant, Biol Neonate, 88, 237, 10.1159/000087587 Ley, 2018, rhIGF-1/rhIGFBP-3 in preterm infants: a phase 2 randomized controlled trial, J Pediatr Harris, 2015, Beyond building better brains: bridging the docosahexaenoic acid (DHA) gap of prematurity, J Perinatol, 35, 1, 10.1038/jp.2014.195 Connor, 2007, Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis, Nat Med, 13, 868, 10.1038/nm1591 Pawlik, 2014, Fish-oil fat emulsion supplementation reduces the risk of retinopathy in very low birth weight infants: a prospective, randomized study, JPEN J Parenter Enteral Nutr, 38, 711, 10.1177/0148607113499373 Pawlik, 2011, Fish-oil fat emulsion supplementation may reduce the risk of severe retinopathy in VLBW infants, Pediatrics, 127, 223, 10.1542/peds.2010-2427 Beken, 2014, The influence of fish-oil lipid emulsions on retinopathy of prematurity in very low birth weight infants: a randomized controlled trial, Early Hum Dev, 90, 27, 10.1016/j.earlhumdev.2013.11.002 Najm, 2017, Effects of a lipid emulsion containing fish oil on polyunsaturated fatty acid profiles, growth and morbidities in extremely premature infants: a randomized controlled trial, Clin Nutr ESPEN, 20, 17, 10.1016/j.clnesp.2017.04.004 Simmer, 2005, Early introduction of lipids to parenterally-fed preterm infants, Cochrane Database Syst Rev Smithers, 2008, Effect of long-chain polyunsaturated fatty acid supplementation of preterm infants on disease risk and neurodevelopment: a systematic review of randomized controlled trials, Am J Clin Nutr, 87, 912, 10.1093/ajcn/87.4.912 Yui, 2015, Eicosanoids derived from arachidonic acid and their family prostaglandins and cyclooxygenase in psychiatric disorders, Curr Neuropharmacol, 13, 776, 10.2174/1570159X13666151102103305 Sennlaub, 2003, Cyclooxygenase-2 in human and experimental ischemic proliferative retinopathy, Circulation, 108, 198, 10.1161/01.CIR.0000080735.93327.00 Yanni, 2009, The role of PGE2 receptor EP4 in pathologic ocular angiogenesis, Invest Ophthalmol Vis Sci, 50, 5479, 10.1167/iovs.09-3652 Daniel, 1999, Thromboxane A2 is a mediator of cyclooxygenase-2 dependent endothelial migration and angiogenesis, Cancer Res, 59, 4574 Hardy, 2000, Oxidants, nitric oxide and prostanoids in the developing ocular vasculature: a basis for ischemic retinopathy, Cardiovasc Res, 47, 489, 10.1016/S0008-6363(00)00084-5 Hammerman, 2008, Indomethacin and retinopathy of prematurity: the hidden paradox, J Pediatr, 153, 587, 10.1016/j.jpeds.2008.05.009 Avila-Vazquez, 2004, Treatment of retinopathy of prematurity with topical ketorolac tromethamine: a preliminary study, BMC Pediatr, 7, 415 Nandgaonkar, 1999, Indomethacin improves oxygen-induced retinopathy of prematurity in the mouse, Pediatr Res, 46, 184, 10.1203/00006450-199908000-00010 Sharma, 2003, Ibuprofen improves oxygen-induced retinopathy in a mouse model, Curr Eye Res, 27, 309, 10.1076/ceyr.27.5.309.17222 Takahashi, 2003, Topical nepafenac inhibits ocular neovascularization, Invest Ophthalmol Vis Sci, 44, 409, 10.1167/iovs.02-0346 Phelps, 1987, Tocopherol efficacy and safety for preventing retinopathy of prematurity: a randomized, controlled, double-masked trial, Pediatrics, 79, 489, 10.1542/peds.79.4.489 Rosenbaum AL, Phelps DL, Isenberg SJ, Leake RD, Dorey F. Retinal hemorrhage in retinopathy of prematurity associated with tocopherol treatment. Krinsky, 2003, Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye, Ann Rev Nutr, 23, 171, 10.1146/annurev.nutr.23.011702.073307 Ribaya-Mercado, 2004, Lutein and zeaxanthin and their potential roles in disease prevention, J Am Coll Nutr, 23, 567S, 10.1080/07315724.2004.10719427 Dani, 2012, Lutein and zeaxanthin supplementation in preterm infants to prevent retinopathy of prematurity: a randomized controlled study, J Matern Fetal Neonatal Med, 25, 523, 10.3109/14767058.2011.629252 Romagnoli, 2011, A prospective, randomized, double blind study comparing lutein to placebo for reducing occurrence and severity of retinopathy of prematurity, J Matern Fetal Neonatal Med, 24, 147, 10.3109/14767058.2011.607618 Manzoni, 2013, Lutein and zeaxanthin supplementation in preterm very low-birth-weight neonates in neonatal intensive care units: a multicenter randomized controlled trial, Am J Perinatol, 30, 25 Storch, 2010, Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action, Br J Dermatol, 163, 269, 10.1111/j.1365-2133.2010.09848.x Ristori, 2011, Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade, Invest Ophthalmol Vis Sci, 52, 155, 10.1167/iovs.10-5536 Filippi, 2013, Oral propranolol for retinopathy of prematurity: risks, safety concerns, and perspectives, J Pediatr, 163, 1570, 10.1016/j.jpeds.2013.07.049 Kaempfen, 2018, Beta-blockers for prevention and treatment of retinopathy of prematurity in preterm infants, Cochrane Database Syst Rev, 3 Filippi, 2017, Propranolol 0.1% eye micro-drops in newborns with retinopathy of prematurity: a pilot clinical trial, Pediatr Res, 81, 307, 10.1038/pr.2016.230 Beharry, 2016, Pharmacologic interventions for the prevention and treatment of retinopathy of prematurity, Semin Perinatol, 40, 189, 10.1053/j.semperi.2015.12.006